Profile picture

Doctor Alex Byrne

Godalming (United Kingdom of Great Britain & Northern Ireland)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

A study to assess the ability of the HFA-ICOS risk stratification tool to predict cancer therapy-related cardiac dysfunction for patients receiving anthracycline chemotherapy.
Presentation
A study to assess the ability of the HFA-ICOS risk stratification tool to predict cancer therapy-related cardiac dysfunction for patients receiving anthracycline chemotherapy.
Read more
OCT versus angiography for post insertion assessment of everolimus-eluting bioresorbale vascular scaffolds and the prevention of major adverse cardiovascular events.
Presentation
OCT versus angiography for post insertion assessment of everolimus-eluting bioresorbale vascular scaffolds and the prevention of major adverse cardiovascular events.
Read more

ESC 365 is supported by

novartis Explore sponsored resources